-
Featured Authors
Archive
- February 2015 (1)
- January 2015 (2)
- December 2014 (1)
- November 2014 (1)
- September 2014 (1)
- August 2014 (3)
- July 2014 (1)
- June 2014 (1)
- May 2014 (1)
- April 2014 (1)
- February 2014 (3)
- January 2014 (2)
- December 2013 (2)
- November 2013 (1)
- October 2013 (1)
- September 2013 (2)
- August 2013 (2)
- July 2013 (1)
- April 2013 (1)
- February 2013 (4)
- January 2013 (2)
- December 2012 (1)
- November 2012 (2)
- October 2012 (2)
- August 2012 (1)
- July 2012 (2)
- June 2012 (2)
- May 2012 (1)
- April 2012 (1)
- March 2012 (1)
- December 2011 (1)
- August 2011 (2)
- July 2011 (1)
- June 2011 (5)
- May 2011 (1)
- March 2011 (1)
- February 2011 (1)
- January 2011 (2)
- December 2010 (1)
- November 2010 (2)
- October 2010 (1)
- September 2010 (1)
- August 2010 (1)
- July 2010 (2)
- May 2010 (1)
- April 2010 (1)
- March 2010 (2)
- February 2010 (6)
- January 2010 (1)
- November 2009 (2)
- October 2009 (2)
- September 2009 (1)
- August 2009 (2)
- July 2009 (3)
- June 2009 (2)
- May 2009 (6)
- March 2009 (1)
Category Archives: Jim’s Corner
Research: Working Together Toward Cures
Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By bringing together the brightest minds in medical research, our nation’s research enterprise has successfully brought hundreds of new drugs, biologics, and vaccines to market in recent years and developed a wealth of clinical prescribing information. Ongoing research is advancing the fight against some of humanity’s worst scourges, such as Read More >
20th Anniversary of the BIO International Convention
Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 in Chicago. From a small beginning, our convention has grown into the most influential biotech meeting in the world, attracting more than 16,500 attendees from 65 countries and providing a wide array of education, exhibits and networking opportunities — including more than 25,000 partnering meetings expected during the 4-day event. As we look forward to the upcoming Convention, I cannot Read More >
“When Genetic Engineering Came Of Age”
October 29 was the 30th anniversary of the approval by the Food and Drug Administration (FDA) of human insulin synthesized in genetically engineered bacteria. In an article for Forbes, Henry Miller, the founding director of the FDA’s Office of Biotechnology, marked the anniversary and commented on today’s regulatory environment: “Regulators have adopted a highly risk-averse and even adversarial mindset, few new drugs are approved without convening extramural advisory committees, and decisions are sometimes hijacked by Read More >
Sacrificing Energy Independence is Not the Solution
This past summer, as parts of the Midwest faced historic droughts and farmers and ranchers struggled with the impact of failing crops, a group of governors petitioned the Environmental Protection Agency (EPA) to suspend the federal Renewable Fuels Standard (RFS) as a way to provide relief. As temperatures cool and the drought stabilizes, it’s clear that government programs to provide emergency assistance for farmers and ranchers worked as intended. Yet, the call to suspend the Read More >
Spreading BIO’s Message at the National Political Conventions
Next week, the Republican National Convention kicks-off in Tampa, Florida. The week after that, the Democratic National Convention will be held in Charlotte, North Carolina. Aside from the nomination of the national party tickets and the tremendous media coverage generated by these events, key opinion leaders from both parties will converge on these cities to participate in this uniquely American process. An important component of our ongoing advocacy work is to educate these key decision Read More >
